Low Toxicity / Immunogenicity

Verheesen P, de Kluijver A, van Koningsbruggen S, de Brij M, de Haard HJ, van Ommen GJ, van der Maarel SM, Verrips CT.  Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.  Hum Mol Genet. 2006 Jan 1; 15 (1): 105-11.

Gibbs WW.  Nanobodies.  Sci Am. 2005 Aug; 293 (2): 78-83.

Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De Baetselier P, Muyldermans S, Revets H.  Efficient cancer therapy with a nanobody-based conjugate.  Cancer Res. 2004 Apr 15; 64 (8): 2853-7.

Cortez-Retamozo V, Lauwereys M, Hassanzadeh Gh-G, Gobert M, Muyldermans S, De Baetselier P, Revets H.  Efficient tumor targeting by single-domain antibody fragments of camels.  Int J Cancer. 2002 Mar 20; 98 (3): 456-62.

Muyldermans S.  Single domain camel antibodies: current status.  J Biotechnol. 2001 Jun; 74 (4): 277-302.

< back